Pharmacolog SARL has received an order for a DrugLog® system for placement at Hôpital Saint Camille in Bry sur Marne, France. The system will be used for the final check of chemotherapy preparations at the hospital pharmacy.
Pharmacolog SARL has received an order for a DrugLog® system which will be placed at Saint Camille Hospital in Bry sur Marne. The system will be used for final control of chemotherapy preparations compounded in the laminar flow of the clean room at the hospital pharmacy. The project is going to start in January with the calibration and qualification of the first cytotoxic drugs.
The private and general Hôpital Saint Camille with 244 inpatient and 30 outpatient beds is a recognized private institution participating in the public hospital service in Eastern Paris. It offers patients a range of diversified care in medicine, surgery, emergency management, ICU, adult and pediatric oncology. They are specialized in lung cancer, digestive cancers, gynecological and urological cancers. Order value is approximately 450.000SEK.
Didier Dubois, Sales Manager Pharmacolog SARL comments: “I am pleased that Hôpital Saint Camille has selected DrugLog® for quality control of prepared cytotoxic preparations. DrugLog® will be an excellent addition to the new facility for chemo preparation at their hospital pharmacy. A big thank you to the staff at Saint Camille for their confidence in the implementation of this project.“
For more information contact:
Mats Högberg, CEO
Email: mats.hogberg@pharmacolog.com
Phone: +46 70-546 50 21
This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on December 8, at 14:15.
About Pharmacolog AB
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products, DrugLog®, WasteLog® and PrepLog®, help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.
Further information regarding the company is available at http://www.pharmacolog.com.
The company's Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
Release